SureTrader
Home > Boards > US OTC > Biotechs > NorthWest Biotherapeutics Inc. (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 32
Posts 2,533
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 5:12:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 5:02:42 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2018 6:34:40 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/9/2018 11:44:15 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/25/2018 2:30:45 PM
Halitron, Inc. - HAON Announces $3 Million Asset, Stock Buyback to .01 InvestorsHub NewsWire - 1/22/2018 7:05:31 AM
Life's Time Capsule (LTCP) Taps into the Biggest Business in the World - The Church InvestorsHub NewsWire - 1/18/2018 7:18:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/16/2018 5:23:28 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/10/2018 2:02:52 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 1/9/2018 4:31:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/9/2018 12:25:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2018 5:13:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/4/2018 4:29:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2017 8:02:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2017 4:33:36 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/5/2017 5:25:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2017 6:05:58 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/20/2017 5:33:26 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/14/2017 5:20:39 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/24/2017 3:19:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/16/2017 5:28:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/22/2017 5:11:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/22/2017 4:18:34 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/22/2017 8:58:57 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 9/11/2017 2:46:27 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 158645 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist